716 related articles for article (PubMed ID: 20427750)
1. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.
Allen R; Chen C; Soaita A; Wohlberg C; Knapp L; Peterson BT; García-Borreguero D; Miceli J
Sleep Med; 2010 Jun; 11(6):512-9. PubMed ID: 20466589
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
5. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
[TBL] [Abstract][Full Text] [Related]
7. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
10. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L; Asgharian A; Hunter B
Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pregabalin with pramipexole for restless legs syndrome.
Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP
Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755
[TBL] [Abstract][Full Text] [Related]
14. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
[TBL] [Abstract][Full Text] [Related]
15. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
Garcia-Borreguero D; Winkelman J; Adams A; Ellis A; Morris M; Lamb J; Layton G; Versavel M;
Sleep Med; 2007 Mar; 8(2):119-27. PubMed ID: 17239657
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.
Trenkwalder C; Hundemer HP; Lledo A; Swieca J; Polo O; Wetter TC; Ferini-Strambi L; de Groen H; Quail D; Brandenburg U;
Neurology; 2004 Apr; 62(8):1391-7. PubMed ID: 15111679
[TBL] [Abstract][Full Text] [Related]
18. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
Montplaisir J; Karrasch J; Haan J; Volc D
Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
[TBL] [Abstract][Full Text] [Related]
19. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
20. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
Dauvilliers Y; Benes H; Partinen M; Rauta V; Rifkin D; Dohin E; Goldammer N; Schollmayer E; Schröder H; Winkelman JW
Am J Kidney Dis; 2016 Sep; 68(3):434-43. PubMed ID: 26851201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
